StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$13.22−0.23 (-1.71%)

Close on Nov 20, 2026Market cap $2.31BP/E 5.1Yield –

HUTCHMED (China) gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $212.16M, down 24.6% from the year before. The highest annual figure on record is $453.55M in fiscal 2023.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$212.16M-24.6%
FY2024Dec 31, 2024$281.32M-38.0%
FY2023Dec 31, 2023$453.55M+293.3%
FY2022Dec 31, 2022$115.31M+61.4%
FY2017Dec 31, 2017$71.44M+6.7%
FY2016Dec 31, 2016$66.95M-8.7%
FY2015Dec 31, 2015$73.34M+116.7%
FY2014Dec 31, 2014$33.85M–

More HUTCHMED (China) figures

See a number that looks wrong?